Mukka Proteins FY26 Financial Update

Mukka Proteins reported strong financial results for the fiscal year 2026 (FY26). Consolidated revenue surged by 44.02% year-on-year to ₹1,449.45 crore. Consolidated profit after tax also grew, reaching ₹57.09 crore, an increase of 18.69% from FY25.

However, the company's performance in the fourth quarter of FY26 (Q4 FY26) showed a mixed picture. Revenue for the quarter was largely flat, down 0.25% year-on-year at ₹380.60 crore, with profit standing at ₹21.36 crore.

On a standalone basis, Mukka Proteins saw revenue climb 38.62% to ₹1,229.21 crore for the full year. Profit on a standalone basis, however, increased only marginally by 1.75% to ₹42.41 crore. This smaller profit growth indicates that expenses rose faster than revenue for the standalone operations.

A significant concern for the company is its escalating debt. Consolidated current borrowings jumped from ₹447.76 crore in FY25 to ₹735.67 crore in FY26. Critically, this short-term debt of ₹735.67 crore now exceeds the company's total equity of ₹528.78 crore. This high level of leverage presents a considerable financial risk.

Despite these financial pressures, Mukka Proteins is pursuing international growth. The company has approved plans for international expansion, including establishing a joint venture and acquiring a stake in a Sri Lankan entity. These moves signal ambitions to diversify beyond its domestic market.

The company previously conducted its Initial Public Offering (IPO) in March 2024. The funds raised from the IPO were earmarked for working capital needs and expansion projects, such as increasing production capacity.

In comparison to peers, Mukka Proteins' FY26 performance stands out. Companies like Avanti Feeds Ltd and Waterbase Ltd, also in the aquaculture and feed sector, experienced revenue declines in FY24. While their profits also dipped, Mukka's FY26 results show continued annual profit growth, though its revenue expansion outpaced profit growth.

Key financial figures from the previous fiscal year (FY25) provide context: Consolidated revenue was ₹10,064.16 million (₹1,006.42 crore), and consolidated profit was ₹480.97 million (₹48.10 crore). Standalone revenue was ₹8,867.43 million (₹886.74 crore), and standalone profit was approximately ₹416.82 million (₹41.68 crore).

Investors will be closely watching several factors moving forward. Management's strategies for debt reduction and improving interest coverage ratios will be critical. Performance updates from the new Sri Lankan overseas entity and the joint venture will also be important. Sustaining standalone profit margins amidst rising operational costs and ensuring adequate cash flow for debt servicing are key challenges. The company's announced ₹75 crore fundraising initiatives will also be a point of focus.